Lung Cancer and MET Mutations Symposium
Massive Bio and MET Crusaders hosted a Facebook live event titled, Lung Cancer and Met Mutations Symposium. The live discussion took place on Tuesday, June 29th at 1:00 pm EST on Massive Bio’s Facebook page. The goal of the Lung Cancer and MET Mutations Symposium is to educate cancer patients on the importance of genomic testing, clinical trials, and treatment options for lung cancer patients with MET mutations. Attendees include John Hallick, founder of MET Crusaders Cancer Patient and Caregiver Support Group, Kristin Johnston, Chief Nursing Officer at Massive Bio, and Stephanie Tran, Chief Customer Delivery Manager at Massive Bio.
Some of the topics that covered during the live event include:
- John’s personal cancer treatment journey with lung cancer and MET mutations
- The importance of clinical trials and Next Generation Sequencing for cancer patients with mutations
- Advice for lung cancer or MET mutation patients seeking clinical trials or new treatment options
- The story of how John founded the MET Crusaders Cancer Patient and Caregiver Support Group
Amplification and overexpression of the MET gene causes cancer cells to spread and produce at a faster rate in lung cancer patients. The MET gene is a biomarker for new targeted therapies developed in clinical trials that are available for eligible patients to enroll in.
MET Crusaders Cancer Patient and Caregiver Support Group is a community of lung cancer patients, caregivers, researchers, and physicians dedicated to helping those with MET alterations live normal lives. The full live event discussing lung cancer and MET mutations is available to watch below. Stay tuned for more Massive Bio events soon!